RESUMO
Meibomitis-related keratoconjunctivitis (MRKC) is characterized by meibomitis with corneal epithelial abnormalities, and can be divided into two types: MRKC accompanied with phlyctenular keratitis, and MRKC accompanied with keratoepitheliopathy that is similar to superficial punctate keratopathy (SPK). The purpose of this retrospective study was to investigate the characteristic features of keratoepitheliopathy and treatment outcomes for MRKC. This study involved 27 eyes of 18 MRKC patients (3 males and 15 females). National Eye Institute (NEI) scores and visual acuity were compared at pre and post treatment. All subjects were treated with a small-dose administration of clarithromycin. Keratoepitheliopathy characteristic to MRKC, yet different in appearance from SPK, was noted in 24 of the 27 eyes. Fluorescein staining revealed granular epithelial lesions generally larger than SPK that coexisted with small dark spots. In 17 eyes, keratoepitheliopathy was located within the pupillary zone, and the visual acuity in 12 eyes was less than 1.0. Our findings showed significant improvement in the NEI score in MRKC (p < 0.0001) and in visual acuity (p = 0.0157) post treatment, and the characteristic features of keratoepitheliopathy in MRKC that are often associated with decreased visual acuity were elucidated. The treatment of clarithromycin was found to be effective for MRKC with keratoepitheliopathy.
RESUMO
Blepharitis is a very common disease in ophthalmology, dermatology and allergy practice. It generally follows a chronic course and is frequently associated with objective and/or subjective symptoms such as epiphora, red eye, dandruff, gritty sensation, itching, burning, photophobia, and blurred vision. The purpose of this study is to analyze the prevalence of Demodex spp. in patients with symptoms of chronic blepharitis. An analytical cross-sectional study was conducted in the period between 2016 and 2020. All patients with symptoms of chronic blepharitis who underwent a parasitological test of eyelashes (Rapitest) in the Dermatology Department of the Hospital Italiano de Buenos Aires were included. Those with previously established blepharitis due to another infectious cause were excluded. We analyzed 972 patients. Sixty percent (n=585) underwent a positive Rapitest for the presence of Demodex spp. Seventy five percent (n=728) were women. There were no significant differences in the prevalence associated with sex (p=0.38). Among the patients positive for Demodex spp., 65% (n=628) were older than 60 years old. The most frequently associated symptom was itching, present in 35% (n=342). A statistically significant decrease in the number of consultations was observed during the cold months of the year (May-June-July-August). Our results show a high prevalence of Demodex spp. in patients with chronic blepharitis. As its presence reveals a direct association with age, we recommend looking for this parasite in this age group.
Assuntos
Blefarite , Infestações por Ácaros , Ácaros , Animais , Humanos , Feminino , Pessoa de Meia-Idade , Masculino , Infestações por Ácaros/epidemiologia , Prevalência , Estudos Transversais , Blefarite/epidemiologia , Blefarite/parasitologia , Prurido/complicaçõesRESUMO
PURPOSE: To evaluate the efficacy of azithromycin hydrate ophthalmic solution for the treatment of internal hordeolum and meibomitis with or without phlyctenular keratitis. STUDY DESIGN: Retrospective study. METHODS: Patients diagnosed with internal hordeolum or meibomitis were prescribed azithromycin hydrate ophthalmic solution twice daily for 2 days and then once daily for 12 days. Depending on the presence of meibomitis-related keratoconjunctivitis (MRKC), we further divided the patients with meibomitis into three subgroups: meibomitis alone (non-MRKC group), meibomitis with non-phlyctenular MRKC (non-phlyctenular group), and meibomitis with phlyctenular MRKC (phlyctenular group). Inflammatory findings (eyelid redness and conjunctival hyperemia) were scored before and after treatment. Some patients also underwent culture testing fluids discharged by the meibomian gland orifices. RESULTS: Three patients (3 eyes) had internal hordeolum and 16 patients (16 eyes) had meibomitis. After treatment, the inflammatory findings disappeared in all eyes with internal hordeolum. Among the patients with meibomitis, three eyes were in the non-MRKC, six in the non-phlyctenular, and seven in the phlyctenular group. The inflammatory findings were significantly improved only in the phlyctenular group. Among seven eyes with positive culture results, Cutibacterium acnes was detected in five, and treatment improved the inflammatory findings in all of these eyes. CONCLUSION: Azithromycin hydrate ophthalmic solution is effective for the treatment of inflammatory meibomian gland diseases, including internal hordeolum and meibomitis. In particular, the agent is highly efficient in patients with phlyctenular MRKC.
Assuntos
Blefarite , Terçol , Ceratite , Ceratoconjuntivite , Meibomite , Humanos , Azitromicina , Terçol/tratamento farmacológico , Blefarite/complicações , Blefarite/diagnóstico , Blefarite/tratamento farmacológico , Soluções Oftálmicas , Estudos Retrospectivos , Ceratite/diagnóstico , Ceratite/tratamento farmacológico , Inflamação , Glândulas Tarsais , AntibacterianosRESUMO
INTRODUCTION: Extranodal natural killer/T-cell lymphoma (ENKTL) is a rare type of non-Hodgkin's lymphoma. This report presents a patient with the right lower eyelid ENKTL misdiagnosed as meibomitis repeatedly. CASE PRESENTATION: A 48-year-old woman developed recurrent redness and swelling in right eyelid for 2 years. Three eyelid mass removal operations were performed in local hospitals, and the pathological examination suggested meibomitis. Physical examination showed an induration in the lateral lower eyelid of the right eye, local defect of the eyelid margin, mild entropion, redness and swelling of the surrounding tissues, and temporal bulbar conjunctiva hyperemia. The eyelid lesion was resected and ENKTL was diagnosed by specific immunohistochemical staining and in situ hybridization. The lymphoma resolved with chemotherapy and radiotherapy. The patient was still alive forty-one months after the last operation. CONCLUSION: Our report demonstrates that recurrent eyelid redness and swelling might be a malignant tumor, and clinicians should be vigilant.
RESUMO
Purpose: Dry eye disease (DED) is because of a decrease in the tear film's volume or a change in the composition of tears. Evaporative dry eye is the most common type, which is due to meibomian gland dysfunction (MGD). In this study, the morphology of meibomian glands was evaluated in all kinds of dry eyes to look for any loss of meibomian glands, assess the function of remaining glands, and investigate the relationship between anatomy, function, and severity of DED. Methods: A total of 300 patients were included in the study, with 150 eyes in the study group and 150 in the control group. Meibomian gland morphology was assessed by examining the tarsal plate after everting the eyelids. Tear film function was evaluated using tear film break-up time (TBUT) and Schirmer's test (SCH I and II). Meibomian gland morphology was examined with a slit-lamp under magnification, a transilluminator using a small light emitting diode (LED) bulb, and non-contact meibography using an auto refracto-keratometer (ARK). Results: Females had a higher prevalence of dry eyes in our study. In all, 103 eyes (68.6%) in the study group had evaporative dry eye, making it the most prevalent type. Among the 150 controls, 104 controls with 69.3% had no dry eye symptoms, and in those with symptoms, the evaporative type was the most common, with a 28% prevalence. Conclusion: TBUT should be performed in all patients with detectable MG abnormality. Meibography has high specificity and sensitivity to diagnose MGD and in turn dry eyes and should be considered a routine screening modality.
Assuntos
Síndromes do Olho Seco , Disfunção da Glândula Tarsal , Feminino , Humanos , Glândulas Tarsais/diagnóstico por imagem , Disfunção da Glândula Tarsal/diagnóstico , Síndromes do Olho Seco/etiologia , Lágrimas , Exame Físico/efeitos adversosRESUMO
OBJECTIVE: To present the clinical signs and treatment methods for atypical tumor-like meibomitis in two dogs. ANIMALS STUDIED: A 4-year-old castrated-male Coton de Tulear (Case 1) and a 6-year-old spayed-female Maltese dog (Case 2). PROCEDURE: Full ophthalmic examination revealed a well-circumscribed, firm, and raised solitary mass on the upper eyelid of the left (Case 1) and right eye (Case 2). Case 1 showed a recurrent mass with a diameter of 2-3 mm, which was excised by the referring veterinarian. The possibility of meibomian gland involvement was suggested histopathologically. Case 2 had a history of blepharitis treated with systemic corticosteroids 4 years ago. RESULTS: Topical and systemic antibiotics and anti-inflammatory drugs were administered to reduce inflammation and prevent secondary infections. In Case 1, the mass appeared static at the beginning of medication; however, after stopping antibiotics while tapering steroids, the mass increased in size and was associated with suppurative discharge. In Case 2, the mass continued to grow despite treatment, showing a similar infection pattern. Cytological examination revealed neutrophilic inflammation with cocci infection, and bacterial culture confirmed the presence of Staphylococcus pseudintermedius in both cases. When steroid administration was stopped and antibiotic administration was initiated according to the results of the antibiotic susceptibility test, the mass rapidly decreased in size and completely disappeared. There was no recurrence on follow-up. CONCLUSIONS: A unilateral antibiotic-responsive tumor-like solitary mass on the upper eyelid resolved without surgical treatment. Medical treatment must be considered when treating atypical eyelid masses, and the use of appropriate antibiotics through antibiotic susceptibility testing is important.
Assuntos
Doenças do Cão , Meibomite , Neoplasias , Cães , Masculino , Feminino , Animais , Antibacterianos/uso terapêutico , Meibomite/veterinária , Glândulas Tarsais , Inflamação/tratamento farmacológico , Inflamação/veterinária , Neoplasias/veterinária , Doenças do Cão/tratamento farmacológico , Doenças do Cão/microbiologiaAssuntos
Exantema , Mucosite , Mycoplasma , Síndrome de Stevens-Johnson , Humanos , Mucosite/etiologiaAssuntos
Blefarite , Calázio , Calázio/diagnóstico , Calázio/patologia , Humanos , Glândulas Tarsais/patologia , LágrimasRESUMO
Dry eye disease (DED) is emerging as an eye health pandemic, affecting millions worldwide. The development of novel drugs, drug delivery systems, and targeted therapies for addressing the inflammation in DED necessitates progress in experimental models of DED. Animal models of DED have been created for simulating the two clinically described forms of DED: lacrimal insufficiency and the evaporative DED models. Although most DED models have relied upon rodents, the larger eye size and longer life span of rabbits and the closer resemblance to human lacrimal glands, render rabbits a promising near-ideal model for studying DED. Since the first rabbit DED model was described, numerous modifications including the use of topical epitheliotoxic drugs, neural abolition, activated lymphocytes injection, and surgical dacryoadenectomy have been introduced. The stability of these models, whether short-term or long-term, accordingly guides their experimental or therapeutic utility. A rabbit autoimmune dacryoadenitis model has successfully simulated DED signs and features of lacrimal gland inflammation, as observed in Sjogren's syndrome, that improved with mesenchymal stem cell therapy. This review summarizes the comparative microscopic anatomy of rabbit and human lacrimal glands, various existing rabbit DED models and their respective suitability for understanding pathogenetic mechanism of DED or for experimental drug testing. Also, the insights gained from animal models in dry eye management is described along with the future perspectives. There is still a pressing need of developing rabbit models for studying the pathogenesis of complex ocular surface changes in evaporative and aqueous deficiency DED other than autoimmune dacryoadenitis.
Assuntos
Síndromes do Olho Seco/terapia , Aparelho Lacrimal/diagnóstico por imagem , Lágrimas/metabolismo , Pesquisa Translacional Biomédica/métodos , Animais , Modelos Animais de Doenças , Síndromes do Olho Seco/metabolismo , Humanos , Aparelho Lacrimal/metabolismo , CoelhosRESUMO
Introducción: Existe creciente interés en Demodex y su asociación con condiciones como rosácea, blefaritis, chalazión, meibomitis y queratoconjuntivitis. El manejo con ivermectina ha sido ampliamente reportado tanto en dermatología como en oftalmología. Objetivo: Revisar la literatura para determinar el papel de Demodex en la inflamación de la superficie ocular y el uso de ivermectina en su tratamiento. Diseño del estudio: Revisión de la literatura. Método: Búsqueda de artículos en PubMed con los siguientes términos: Demodex, rosácea ocular, chalazión, rosácea pediátrica, meibomitis, queratoconjuntivitis e ivermectina. Resultados: Se presenta una revisión de generalidades, epidemiología y fisiopatología de la inflamación ocular asociada a Demodex. Se resume el conocimiento actual sobre rosácea y Demodex, y el papel de este como disparador de procesos inflamatorios como chalazión, blefaritis, meibomitis, queratoconjuntivitis y rosácea ocular. Se citan estudios relevantes sobre el manejo de ivermectina en las condiciones mencionadas. Conclusiones: La evidencia reciente otorga a Demodex el papel de un agente disparador de varias condiciones inflamatorias de la superficie ocular. Si bien se requieren más estudios para determinar la efectividad de la ivermectina tópica, el conocimiento actual permite pensar que puede ser útil contra Demodex por su capacidad acaricida
Background: There has been increasing interest in Demodex and its association with conditions such as rosacea, blepharitis, chalazion, meibomitis and keratoconjunctivitis; and ivermectin as a treatment has been reported both in dermatology and ophthalmology. Objective: To review the literature in order to determine the role of Demodex in ocular surface inflammation and the use of ivermectin for its treatment. Study design: Review of the literature. Methods: An article search was done in PubMed with the following terms: Demodex, ocular rosacea, chalazion, pediatric rosacea, meibomitis, keratoconjunctivitis and ivermectin. Results: A review including the epidemiology and pathophysiology of ocular inflammation associated with Demodex is presented. Current knowledge on Demodex and rosacea, chalazion, blepharitis, meibomitis, keratoconjunctivitis and ocular rosacea is summarized. Relevant articles on the use of ivermectin for these conditions are listed. Conclusions: Recent evidence suggests Demodex is a trigger for a number of ocular surface inflammatory conditions. Although more studies are necessary to determine the effectiveness of topical ivermectin, current knowledge supports its acaricidal action against Demodex
Assuntos
HumanosRESUMO
Sebaceous adenitis and concurrent meibomian gland dysfunction (MGD) were diagnosed in a two-year-old mongrel dog presenting with hypotrichosis, exfoliative dermatitis and blepharitis. Diagnosis of sebaceous adenitis was based on history, clinical signs, the histological demonstration of multifocal lymphohistiocytic and neutrophilic inflammation targeting the sebaceous glands and sebaceous glands loss. MGD was diagnosed by non-contact infrared meibography followed by tear film lipid layer interferometric evaluation. Ciclosporin and sebolytic shampoos controlled the dermatological condition, while doxycycline, warm compresses, palpebral massages and tobramycin/dexamethasone ointment controlled the blepharitis. This case report should stimulate clinicians to investigate MGD in dogs suffering from sebaceous adenitis, because the meibomian and sebaceous glands share similar anatomy and physiology.
RESUMO
Measles is a contagious viral infection that usually affects children. The disease is caused by morbillivirus, a virus of the family Paramyxoviridae. The clinical picture is characterized by four phases: incubation, invasion, eruption and desquamation. Ophthalmologic manifestations in measles are rare, dominated by conjunctivitis and keratitis. Corneal involvement is the main concern; it varies from simple superficial punctate keratitis to corneal perforation. We report three cases of acute keratitis in young adults during an epidemic. The epithelial involvement was peripheral, central or diffuse. The outcome was favorable under symptomatic topical treatment.
Assuntos
Infecções Oculares Virais/diagnóstico , Sarampo/diagnóstico , Adulto , Fatores Etários , Antivirais/administração & dosagem , Blefarite/diagnóstico , Blefarite/tratamento farmacológico , Blefarite/virologia , Conjuntivite/diagnóstico , Conjuntivite/tratamento farmacológico , Conjuntivite/virologia , Infecções Oculares Virais/tratamento farmacológico , Feminino , Humanos , Ceratite/diagnóstico , Ceratite/tratamento farmacológico , Ceratite/virologia , Lubrificantes Oftálmicos/administração & dosagem , Masculino , Sarampo/tratamento farmacológico , Sarampo/patologia , Pessoa de Meia-Idade , Soluções Oftálmicas/administração & dosagem , Vitamina A/administração & dosagemRESUMO
BACKGROUND: Phlyctenular keratitis is a hypersensitivity reaction of the cornea, and a complication of eyelid margin disease in children and young adults. In this study, we compared the morphology of the meibomian glands in eyelids between phlyctenular keratitis patients and healthy young adults, using noncontact meibography. METHODS: The study included 16 eyes of 13 patients diagnosed with phlyctenular keratitis and 17 eyes of 17 healthy volunteers. Slit-lamp observations of the cornea and eyelid were performed on all subjects. The morphology of the meibomian glands was scored using non-contact meibography (meiboscore). The meiboscore in worse eye was used in bilateral phlyctenular keratitis. RESULTS: All eyes with phlyctenular keratitis, but not normal controls, showed corneal nodules, neovascularization, and superficial punctate keratopathy. The mean meiboscore in phlyctenular keratitis patients (upper lid: 2.9 ± 0.3, lower lid: 2.7 ± 0.5) was significantly higher than in controls (upper lid: 0.4 ± 0.6, lower lid: 0.1 ± 0.3). CONCLUSIONS: Noncontact meibography enabled visualization of meibomian gland loss in phlyctenular keratitis patients, suggesting a relationship between abnormalities of the meibomian glands in young individuals and the pathogenesis of phlyctenular keratitis.
Assuntos
Doenças Palpebrais/patologia , Ceratite/patologia , Glândulas Tarsais/patologia , Adolescente , Adulto , Estudos de Casos e Controles , Criança , Neovascularização da Córnea/patologia , Estudos Transversais , Doenças Palpebrais/diagnóstico , Feminino , Humanos , Masculino , Adulto JovemRESUMO
The purpose of this review was to systematically analyze publications related to the role of meibomian gland disease in ocular surface inflammation, with special reference to meibomitis as an inflammatory form of meibomian gland dysfunction (MGD). Meibomian gland inflammation is often present with the ocular surface inflammation in conditions such as blepharokeratoconjunctivitis, ocular rosacea, and phlyctenular keratitis, but its contribution is often overlooked, especially in younger subjects. This can result in misdiagnosis, mistreatment, and, sometimes, severe visual impairment. We identified a related disease entity, seen predominantly in young patients, of ocular surface inflammation associated with meibomitis, which we termed meibomitis-related keratoconjunctivitis. Its specific clinical features are similar to those observed in the above-mentioned diseases, and the inflammatory form of MGD was found to be closely involved in the ocular surface inflammation seen in those four diseases, based on our statistical evaluation. The diagnosis and management of meibomitis, an inflammatory form of MGD, is vital for the successful treatment of the induced ocular surface inflammation. We propose that the ocular surface and the adnexal meibomian glands should be considered as one unit, i.e., the "meibomian gland and ocular surface" (MOS), when encountered in the clinical setting.